Revolution Medicines Just Hit a Major Milestone. Is the Stock a Buy?

Key Points Revolution Medicines validated its approach to treating certain cancers with a recent regulatory approval. The company's new medicine might become the top-prescribed treatment in its indication. Revolution Medicines is an innovative biotech, but there are valuation concerns to consider before investing. 10 stocks we like better than Revolution Medicines › Revolution Medicines (NASDAQ:RVMD) has been on a tear over the past year, with the company's shares climbing by 340%, as of writing. As is often the case with clinical-stage biotechs, the company's run has been driven by impressive clinical progress. And the good news is that Revolution Medicines recently earned approval for its first product.